 The purpose of this study is to assess the tolerability and efficacy of inhaled theophylline ADC4022 on markers of pulmonary inflammation white blood cells in induced sputum and in bronchial biopsy samples in subjects with moderate to severe Chronic Obstructive Pulmonary Disease COPD when co-administered with budesonide and compared to placebo. 